These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21147498)

  • 1. ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival.
    Zhu Y; Yu M; Li Z; Kong C; Bi J; Li J; Gao Z; Li Z
    Urology; 2011 Feb; 77(2):510.e1-5. PubMed ID: 21147498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gli2 expression and human bladder transitional carcinoma cell invasiveness.
    Mechlin CW; Tanner MJ; Chen M; Buttyan R; Levin RM; Mian BM
    J Urol; 2010 Jul; 184(1):344-51. PubMed ID: 20488474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does RNA editing play a role in the development of urinary bladder cancer?
    Zilberman DE; Safran M; Paz N; Amariglio N; Simon A; Fridman E; Kleinmann N; Ramon J; Rechavi G
    Urol Oncol; 2011; 29(1):21-6. PubMed ID: 19186082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?
    Soukup V; Babjuk M; Dusková J; Pesl M; Szakáczová M; Zámecník L; Dvorácek J
    Urol Int; 2008; 80(4):413-8. PubMed ID: 18587253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma.
    Tsui KH; Cheng AJ; Chang Pe; Pan TL; Yung BY
    Urology; 2004 Oct; 64(4):839-44. PubMed ID: 15491744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Loss of p16 gene in bladder cancer and genitourinary carcinoma cell lines].
    Guo D; Gu F; Zhou A
    Zhonghua Wai Ke Za Zhi; 1996 Nov; 34(11):643-4. PubMed ID: 9590746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder carcinoma: understanding advanced and metastatic disease with potential molecular therapeutic targets.
    Ahmed HU; Arya M; Patel HR
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):1011-22. PubMed ID: 16336092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of nm23-H1 in the progression of transitional cell bladder cancer.
    Chow NH; Liu HS; Chan SH
    Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vascular endothelial growth factor and its receptor inhibitor on proliferation and invasion in bladder cancer.
    Nakanishi R; Oka N; Nakatsuji H; Koizumi T; Sakaki M; Takahashi M; Fukumori T; Kanayama HO
    Urol Int; 2009; 83(1):98-106. PubMed ID: 19641368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes.
    Wang X; Colby JK; Rengel RC; Fischer SM; Clinton SK; Klein RD
    Mol Carcinog; 2009 Jan; 48(1):1-13. PubMed ID: 18444251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Karyometry of bladder washings for the follow up of patients with transitional cell carcinoma of the bladder.
    van der Poel HG; Oosterhof GO; Schaafsma HE; Wiersma-van Tilburg A; Debruyne FM; Schalken JA
    Prog Clin Biol Res; 1992; 378():9-18. PubMed ID: 1301590
    [No Abstract]   [Full Text] [Related]  

  • 14. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion.
    Wang F; Li X; Xie X; Zhao L; Chen W
    FEBS Lett; 2008 Jun; 582(13):1919-27. PubMed ID: 18501714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers.
    Yu Y; Yang JL; Markovic B; Jackson P; Yardley G; Barrett J; Russell PJ
    Clin Cancer Res; 1997 Jul; 3(7):1045-9. PubMed ID: 9815782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro and in vivo evaluation of inhibitory nucleic acid constructs for specific therapy of human urinary bladder carcinoma].
    Kunze D; Füssel S; Meye A; Wuttig D; Krämer K; Kotzsch M; Toma M; Schwenzer B; Kausch I; Jocham D; Hakenberg OW; Grimm MO; Wirth MP
    Urologe A; 2007 Sep; 46(9):1289. PubMed ID: 17665160
    [No Abstract]   [Full Text] [Related]  

  • 17. [Growth inhibition and mechanisms of human bladder cancer T24 cells by adenovirus-mediated ING4 gene in vitro].
    Zhang ZG; Ouyang J; Han CH; Yang JC; Yang HC; Long JH; Ding X
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(42):3008-13. PubMed ID: 21211316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overstaging of transitional cell carcinoma: clinical significance of lamina propria fat within the urinary bladder.
    Bochner BH; Nichols PW; Skinner DG
    Urology; 1995 Mar; 45(3):528-31. PubMed ID: 7879346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma.
    Tiguert R; Bianco FJ; Oskanian P; Li Y; Grignon DJ; Wood DP; Pontes JE; Sarkar FH
    J Urol; 2001 Dec; 166(6):2155-60. PubMed ID: 11696726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p63 gene expression study and early bladder carcinogenesis.
    Compérat E; Bièche I; Dargère D; Ferlicot S; Laurendeau I; Benoît G; Vieillefond A; Verret C; Vidaud M; Capron F; Bedossa P; Paradis V
    Urology; 2007 Sep; 70(3):459-62. PubMed ID: 17905096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.